NMR spectroscopy and electron microscopy identification of metabolic and ultrastructural changes to the kidney following ischemia-reperfusion injury.

Cellular, molecular, and ultrastructural nephron changes associated with ischemia-reperfusion injury-induced acute kidney injury (IRI-AKI) are not completely understood. Here, a multidisciplinary study was used to identify nephron changes in a mouse model of IRI-AKI. Histological analyses indicated distended Bowman's glomerular spaces and proximal and distal tubules. Increased filtrate volume in nephrons was caused by reduced water reabsorption by severely damaged proximal tubule brush borders and blocked flow of filtrate into collecting tubules by mucoprotein casts in distal tubules. Immunohistochemistry revealed protein AKI biomarkers in proximal tubules and glomeruli but not in distal tubules. Nuclear magnetic resonance spectroscopy revealed several metabolites that increased such as valine, alanine, and lactate. Other metabolites such as trigonelline, succinate, 2-oxoisocaproate, and 1- methyl-nicotinamide decreased or were absent in urine following IRI due to altered kidney function or metabolism. Urinary glucose increased due to reduced reabsorption by damaged proximal tubule brush borders. Scanning electron microscopy revealed flattening of podocytes and pedicals surrounding glomerular capillaries, and transmission electron microscopy (TEM) revealed effacement of podocyte pedicals, both consistent with increased hydrostatic pressure in nephrons following IRI-AKI. TEM revealed shortened proximal tubule microvilli in IRI kidneys with diminished lamina propia. TEM showed dramatic loss of mitochondria in distal tubule epithelia of IRI kidneys and emergence of multivesicular bodies of endosomes indicating ongoing cellular death. Collectively, the data define ultrastructural changes to nephrons and altered kidney metabolism associated with IRI-AKI.

[1]  R. Bellomo,et al.  Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup , 2017 .

[2]  M. Hirschey,et al.  Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases , 2017, Nature Reviews Nephrology.

[3]  P. Devarajan,et al.  Pediatric acute kidney injury: prevalence, impact and management challenges , 2017, International journal of nephrology and renovascular disease.

[4]  Liangcai Zhao,et al.  Identification of key metabolic changes in renal interstitial fibrosis rats using metabonomics and pharmacology , 2016, Scientific Reports.

[5]  X. Ye,et al.  Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice , 2015, Scientific Reports.

[6]  Rafael Brüschweiler,et al.  Unified and Isomer-Specific NMR Metabolomics Database for the Accurate Analysis of 13C–1H HSQC Spectra , 2014, ACS chemical biology.

[7]  Beverley Matthews,et al.  The economic impact of acute kidney injury in England. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Raymond Vanholder,et al.  Acute kidney injury: an increasing global concern , 2013, The Lancet.

[9]  I. Wilson,et al.  Hippurate: the natural history of a mammalian-microbial cometabolite. , 2013, Journal of proteome research.

[10]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[11]  A. Şimşek,et al.  New Biomarkers for the Quick Detection of Acute Kidney Injury , 2012, ISRN nephrology.

[12]  Z. Dong,et al.  Mouse model of ischemic acute kidney injury: technical notes and tricks. , 2012, American journal of physiology. Renal physiology.

[13]  N. Ambalavanan,et al.  Urine biomarkers predict acute kidney injury in newborns. , 2012, The Journal of pediatrics.

[14]  D. Basile,et al.  Pathophysiology of acute kidney injury. , 2012, Comprehensive Physiology.

[15]  M. Relling,et al.  Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients , 2012, Clinical Cancer Research.

[16]  S. Goldstein,et al.  Baseline Values of Candidate Urine Acute Kidney Injury Biomarkers Vary by Gestational Age in Premature Infants , 2011, Pediatric Research.

[17]  F. Madeo,et al.  Polyamines in aging and disease , 2011, Aging.

[18]  E. Siew,et al.  Biological markers of acute kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[19]  J. Kellum,et al.  Acute kidney injury: what's the prognosis? , 2011, Nature Reviews Nephrology.

[20]  P. Devarajan,et al.  Proteomic analysis of acute kidney injury: Biomarkers to mechanisms , 2011, Proteomics. Clinical applications.

[21]  Aaron M. Goodpaster,et al.  Statistical significance analysis of nuclear magnetic resonance-based metabonomics data. , 2010, Analytical biochemistry.

[22]  The changing epidemiology of acute renal failure , 2010, Nature Reviews Nephrology.

[23]  Michael A Kennedy,et al.  NMR‐based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad‐spectrum antibiotic enrofloxacin (Baytril) , 2009, Magnetic resonance in chemistry : MRC.

[24]  M. Rosner,et al.  Acute kidney injury. , 2009, Current drug targets.

[25]  S. Waikar,et al.  Chronic on acute renal failure: long-term implications of severe acute kidney injury. , 2009, JAMA.

[26]  S. Goldstein,et al.  Acute Kidney Injury: General Aspects , 2009 .

[27]  John A Kellum,et al.  Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  S. Waikar,et al.  Diagnosis, epidemiology and outcomes of acute kidney injury. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[29]  R. Bellomo,et al.  Early acute kidney injury and sepsis: a multicentre evaluation , 2008, Critical care.

[30]  E. Hoste,et al.  Epidemiology of acute kidney injury: How big is the problem? , 2008, Critical care medicine.

[31]  J. Bonventre,et al.  Biomarkers of acute kidney injury. , 2008, Annual review of pharmacology and toxicology.

[32]  A. Kribben,et al.  Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. , 2007, American journal of physiology. Renal physiology.

[33]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[34]  N. Serkova,et al.  Biochemical mechanisms of nephrotoxicity: application for metabolomics. , 2007, Expert opinion on drug metabolism & toxicology.

[35]  F. Di Maggio,et al.  BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.

[36]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[37]  J. Nally,et al.  Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. , 2005, Chest.

[38]  John A Kellum,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[39]  Qing Ma,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.

[40]  M. Mitsnefes,et al.  J Am Soc Nephrol 15: 3073–3082, 2004 Amelioration of Ischemic Acute Renal Injury by Neutrophil , 2004 .

[41]  A. Kribben,et al.  Early detection of acute renal failure by serum cystatin C. , 2004, Kidney international.

[42]  B. Lambermont,et al.  Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units , 2004, Intensive Care Medicine.

[43]  M. Mitsnefes,et al.  Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. , 2003, Journal of the American Society of Nephrology : JASN.

[44]  J. Bonventre,et al.  Recent advances in the pathophysiology of ischemic acute renal failure. , 2003, Journal of the American Society of Nephrology : JASN.

[45]  R. Kucherlapati,et al.  Differential gene expression following early renal ischemia/reperfusion. , 2003, Kidney international.

[46]  J. Chan,et al.  Acute kidney failure: a pediatric experience over 20 years. , 2002, Archives of pediatrics & adolescent medicine.

[47]  M. Wyss,et al.  Creatine and creatinine metabolism. , 2000, Physiological reviews.

[48]  Joseph V. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.

[49]  B. Nielsen,et al.  Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. , 1996, Gut.